Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 1

Status

Completed 5Unknown 1

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 5

Sponsor

Cancer Type

Head & Neck 3Tumor-Agnostic 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 68Colonic Neoplasms 22Rectal Neoplasms 21Neoplasm Metastasis 18Neoplasms 15Carcinoma, Non-Small-Cell Lung 8Head and Neck Neoplasms 7Esophageal Neoplasms 6Cholangiocarcinoma 6Lung Neoplasms 5Carcinoma, Squamous Cell 5Carcinoma 5Squamous Cell Carcinoma of Head and Neck 4Prostatic Neoplasms 4Pancreatic Neoplasms 4Breast Neoplasms 4Stomach Neoplasms 2Solid Tumors 2Recurrence 2Kidney Neoplasms 2Gastrointestinal Neoplasms 2Biliary Tract Neoplasms 2Adenocarcinoma Of Esophagus 2Adenocarcinoma 2Unspecified Adult Solid Tumor, Protocol Specific 1Triple Negative Breast Neoplasms 1Solid Tumor, Adult 1Ovarian Neoplasms 1Inflammatory Breast Neoplasms 1Gallbladder Neoplasms 1

Interventions

Cisplatin 33Radiotherapy 23Cetuximab 18Paclitaxel 14Docetaxel 14pembrolizumab 13Carboplatin 12Fluorouracil 10Radiotherapy, Intensity-Modulated 8Nivolumab 8Drug Therapy 7Erlotinib Hydrochloride 6Panitumumab 5dacomitinib 4Radiation 4Methotrexate 4Esophagectomy 4130-nm albumin-bound paclitaxel 4durvalumab 3ON 01910 3Leucovorin 3Gemcitabine 3Chemoradiotherapy 3vandetanib 2palbociclib 2osimertinib 2nedaplatin 2fludarabine 2cabazitaxel 2atezolizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Carcinoma, Squamous Cell × Panitumumab × Clear all
NCT01581840 2024-07-01

Radiochemotherapy With Panitumumab in the Localised Epidermoid Carcinoma of the Anus

Federation Francophone de Cancerologie Digestive

Phase 1/2 Completed
45 enrolled 12 charts
Tumor-Agnostic

Carcinoma, Carcinoma, Squamous Cell

NCT00446446 2022-10-05

PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer)

Amgen

Phase 2 Completed
52 enrolled 17 charts
Head & Neck

Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasms

NCT01077999 2021-04-21

Chemoradiation and Panitumumab for Esophageal Cancer

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 2 Completed
78 enrolled
Gastrointestinal

Adenocarcinoma, Carcinoma, Squamous Cell, Esophageal Neoplasms

NCT00500760 2018-10-17

Study of Addition of Panitumumab to Chemoradiation Therapy in Patients With Locally Advanced Head and Neck Cancer

Amgen

Phase 2 Completed
153 enrolled 18 charts
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT00547157 2017-03-15

Radiotherapy Plus Panitumumab Compared to Chemoradiotherapy With Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Amgen

Phase 2 Completed
152 enrolled 18 charts
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡